Liz Paxton, MA

Director
Kaiser Permanente’s national implant registry program

 

 



Liz Paxton
is the director of Kaiser Permanente’s national implant registry program and led the development of this post-market surveillance program for 10 million members nationwide. Her accomplishments include the development of U.S. total joint, ACL spine, shoulder, hip fracture, cardiac (i.e., ICD, Pacemaker, and, heart valve), and vascular stent registries tracking more than 2 million devices for our members.  Under Ms. Paxton’s leadership, this program has received the Joint Commission Eisenberg National Patient Safety and Quality Award and the ECRI Health Device Achievements Award. Ms. Paxton is a recognized an expert in registry development, implementation, registry science, and outcome assessment with presentations to a wide variety of audiences including FDA public workshops, Academy Health meetings, American Medical Association, national/international orthopedic, and health technology groups. She also served on the Institute of Medicine’s committee evaluating the Public Health Effectiveness of the FDA 510(k) Clearance Process and provided recommendations that were adopted by the FDA in their strategic plan for post-market surveillance. She serves as co-director of the FDA’s International Consortium of Orthopedic Registries (ICOR) responsible for developing a network of national and international registries for FDA postmarket surveillance of orthopedic devices and leads the International Society of Arthroplasty Registries quality committee. Ms. Paxton has over 100 publications on registry development and use as quality improvement mechanisms, identification of patient risk factors for adverse events, evaluation of comparative effectiveness of devices and clinical outcome assessment.